CuraLinc Healthcare, a leading provider of workforce mental health and wellbeing solutions, today announced the appointment of Dave Wynne as Chief Financial Officer (CFO). The move reflects the company’s ongoing growth, following its investment partnership with Lightyear Capital.

In his role, Wynne will lead CuraLinc’s finance and strategic planning functions, partnering with the executive team to drive sustainable growth, guide capital allocation, and scale operational capabilities to accelerate CuraLinc’s impact as a market leader. His appointment supports the company’s continued trajectory of strong growth, product innovation, and market adoption. 

“Dave brings a great combination of mission alignment, operational depth, and strategic vision,” said Derek Newell, CEO of CuraLinc. “His track record leading high-performing teams and scaling mission-driven healthcare and technology companies makes him the ideal partner as we expand our reach and impact.”

Michael Langer, Partner at Lightyear Capital, added: “We’ve built a relationship with Dave over the years and knew he was the right fit for this role. He has a proven ability to drive results in partnership with private equity, and we’re excited to see the impact he’ll have at CuraLinc.”

Wynne brings over two decades of experience in finance and strategy leadership. Most recently, he served as CFO at Hootsuite, where he led a global finance organization through a period of transformative growth. Prior to that, he was CFO at WINFertility, where he drove topline growth, margin expansion, and operational scalability. 

“CuraLinc’s mission deeply resonates with me. Supporting people during their most vulnerable moments is work that matters,” said Wynne. “What’s equally compelling is how clearly the market is responding. CuraLinc is growing rapidly, earning trust with employers, and making a measurable impact. I’m honored to help scale that reach even further.”